Related Experiment Video
Updated: Aug 7, 2026
07:03
Determining Genome-wide Transcript Decay Rates in Proliferating and Quiescent Human Fibroblasts
Published on: January 2, 2018
Gene expression profiling in vLINCL CLN6-deficient fibroblasts: Insights into pathobiology
C A F Teixeira1, S Lin, M Mangas
1Unidade de Enzimologia, Instituto de Genética Médica Jacinto Magalhães, Porto, Portugal.
Biochimica Et Biophysica Acta
|July 22, 2006
Summary
Molecular defects in the CLN6 gene cause a fatal neurodegenerative disease. This study reveals cholesterol accumulation and altered extracellular matrix proteins in affected cells, offering new therapeutic targets.
Area of Science:
- Cell Biology
- Neuroscience
- Genetics
Background:
- Neuronal ceroid lipofuscinosis (NCL) encompasses fatal neurodegenerative diseases.
- The CLN6 variant of NCL results from mutations in the CLN6 gene, encoding an endoplasmic reticulum (ER) transmembrane protein of unknown function.
- Understanding the molecular basis of CLN6 deficiency is crucial for developing effective therapies.
Purpose of the Study:
- To investigate the molecular mechanisms underlying CLN6-related neuronal ceroid lipofuscinosis (vLINCL).
- To identify novel molecular pathways and potential therapeutic targets by analyzing gene expression changes in CLN6-deficient cells.
Main Methods:
- Gene expression profiling of CLN6-deficient fibroblasts using cDNA microarray.
- Validation of key gene expression changes using quantitative real-time PCR (qRT-PCR).
- Biochemical analysis of free cholesterol and gangliosides in CLN6-deficient fibroblasts.
Main Results:
- Identified 12 statistically significant transcript alterations in CLN6-deficient fibroblasts.
- Observed overexpression of versican and tissue factor pathway inhibitor 2, indicating extracellular matrix (ECM) remodeling.
- Detected cholesterol accumulation in lysosomes, suggesting impaired cholesterol homeostasis and potential disruption of signaling pathways and intracellular trafficking.
- Evidence of altered apoptosis and immune/inflammatory responses.
Conclusions:
- CLN6 deficiency leads to significant alterations in ECM composition, cholesterol homeostasis, and intracellular trafficking pathways.
- Cholesterol accumulation and dysfunctional endosomal-lysosomal vesicles may contribute to apoptosis and inflammation in CLN6-related vLINCL.
- These findings provide novel insights into the pathophysiology of CLN6 deficiency and suggest potential biomarkers and therapeutic strategies for neurodegenerative diseases.
